Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review-Reference-Cited by-同舟云学术

Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review

Published:2020-09-04 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Liang Jing‐yao¹²^ORCID,Ye Rui‐xian¹²^ORCID,Tian Xin¹²,Zhang San‐quan¹²,Zhang Xi‐bao¹²^ORCID

Affiliation:

1. Institute of Dermatology Guangzhou Medical University Guangzhou China

2. Department of Dermatology Guangzhou Institute of Dermatology Guangzhou China

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14097

Reference15 articles.

1. A Review on Pityriasis Rubra Pilaris

2. Original article Pityriasis rubra pilaris-an historical approach. 2 CLINICAL FEATURES

3. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris

4. Alitretinoin (9-cis Retinoic Acid) is Effective Against Pityriasis Rubra Pilaris: A Retrospective Clinical Study

5. Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid clearance of extensive juvenile pityriasis rubra pilaris with ixekizumab;Pediatric Dermatology;2024-07-24

2. Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris;Life;2024-07-24

3. Biologics for inherited disorders of keratinisation: A systematic review;Australasian Journal of Dermatology;2023-12-21

4. Successful Treatment of Pityriasis Rubra Pilaris with Risankizumab in Children;Dermatology and Therapy;2023-09-13

5. The Effectiveness of Anti-Interleukin-17A Treatment for Pityriasis Rubra Pilaris: A Systematic Review;Cureus;2023-06-29